Copper Peptides in Skin Research: What the GHK-Cu Literature Covers

Skin is among the most heavily studied tissues in peptide research. It is easy to reach, its remodeling can be measured, and it is full of the extracellular-matrix biology that peptides are tested against. The central compound is GHK-Cu, a tripeptide that binds copper. This is a research summary for lab reference and describes no cosmetic or human use.

Why skin works well as a model

In skin, researchers can watch collagen, elastin and matrix changes fairly directly, which makes it a useful testbed for compounds studied for tissue remodeling. That ease of access is part of why so much of the copper-peptide and signaling-peptide literature focuses on skin.

GHK-Cu as the central compound

GHK was first isolated from human plasma in 1973, and its copper-binding behavior was characterized later. GHK-Cu is studied as a modulator of several cellular pathways tied to skin regeneration, including matrix and collagen-related signaling (Pickart, Vasquez-Soltero & Margolina, BioMed Res Int, 2015). [1] It also has a foundational literature on copper-dependent tissue remodeling (Pickart, J Biomater Sci Polym Ed, 2008). [2]

Note: The findings are preclinical. Material is for laboratory Research Use Only, not for human, cosmetic or veterinary use.

FAQ

Why is GHK-Cu the usual choice for skin research?

It has a literature going back decades on copper-dependent tissue remodeling and skin-regeneration signaling, which makes it one of the most thoroughly studied copper peptides in the field.

References

1. Pickart et al.: GHK and skin-regeneration pathways (BioMed Res Int, 2015)
2. Pickart: GHK and tissue remodeling (J Biomater Sci Polym Ed, 2008)
3. GHK-Cu profile